PRTO News

Three IPOs raised $164 million, bringing the year's total up to 231 offerings and $74 billion in proceeds. Six deals were expected to raise $550 million to make it the first week in over a month to raise under $1 billion. However, three of those postponed, including the two largest, Fifth Street Asset Management and Electronic Cigarettes International, so that the IPO...read more

Proteon Therapeutics, which is developing a treatment to reduce the failure rates of a dialysis-related procedure, raised $61 million by offering 6.1 million shares at $10, below the range of $12 to $14. Proteon Therapeutics plans to list on the NASDAQ under the symbol PRTO. Proteon Therapeutics initially filed confidentially on 6/25/2014. Stifel and JMP Securities acted as lead...read more

5 IPOs are expected to raise $456 million during the week of October 20. After five straight weeks of raising over $1 billion, the IPO market appears to have chilled due to the broader market selloff and weaker returns. Aside from two small health care companies and one small bank offering, this week's hodgepodge of IPOs includes a $200 million deal from Fifth Street Asset...read more

Proteon Therapeutics, a biotech developing a recombinant protein for patients undergoing surgery for kidney failure, announced terms for its IPO on Tuesday. The Waltham, MA-based company plans to raise $61 million by offering 4.7 million shares at a price range of $12 to $14. At the midpoint of the proposed range, it would command a fully diluted market value of $199 million. ...read more